This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2019-2023.
Company Filing History:
Years Active: 2019-2023
Title: Paul Leonard: Innovator in Cancer Treatment
Introduction
Paul Leonard is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer and other diseases.
Latest Patents
Leonard holds 4 patents, with his latest inventions focusing on heterocyclic inhibitors of PTPN11. These compounds are designed to serve as inhibitors of PTPN11, which is crucial for the treatment or prevention of cancer and other PTP-mediated diseases. The disclosed compounds, based on pyrazolopyrazines, have promising applications as pharmaceuticals for disease treatment.
Career Highlights
Paul Leonard is affiliated with the University of Texas System, where he continues to advance his research and innovation in the pharmaceutical field. His work is characterized by a commitment to developing effective treatments for serious health conditions.
Collaborations
Leonard collaborates with esteemed colleagues, including Philip Jones and Barbara Czako, who contribute to his research endeavors and innovations.
Conclusion
Paul Leonard's work in developing heterocyclic inhibitors of PTPN11 showcases his dedication to improving cancer treatment options. His contributions to the field are invaluable and highlight the importance of innovation in healthcare.